Science Explorer Back to mapMap
Discussion
Researcher · Roche (Switzerland) · Switzerland

Johannes Sam

Johannes Sam publishes mostly in Oncology, Radiology, Nuclear Medicine and Imaging and Immunology, on topics such as CAR-T cell therapy research, Monoclonal and Polyclonal Antibodies Research and Cancer Immunotherapy and Biomarkers.

ORCID 0000-0002-7455-0609 OpenAlex
World rank
#89,426
of 7,710,434 ranked researchers
Rank in Switzerland
#1,880
of 80,918
Works
282
Citations
2.9k
Citations per work
10.3
h-index
24
i10-index 28Top 17% in Oncology
Johannes Sam

What does Johannes Sam research?

Johannes Sam's work is mostly in Medicine (66%), Immunology and Microbiology (16%), Biochemistry, Genetics and Molecular Biology (6%).

Health Sciences: 186 works · 65.9% of their workMedicine: 186 works · 65.9% of their workOncology: 100 works · 35.3% of their workRadiology, Nuclear Medicine and Imaging: 77 works · 27.2% of their workPathology and Forensic Medicine: 10 works · 3.4% of their workLife Sciences: 62 works · 21.9% of their workImmunology and Microbiology: 45 works · 15.9% of their workImmunology: 45 works · 15.9% of their workBiochemistry, Genetics and Molecular Biology: 17 works · 6.0% of their workMolecular Biology: 17 works · 6.0% of their workEverything else: 25 works · 8.8% of their workPhysical Sciences: 10 works · 3.4% of their workEngineering: 10 works · 3.4% of their workBiomedical Engineering: 10 works · 3.4% of their workTHEIR WORKJohannes Sam282works
Life Sciences22%Physical Sciences3%Health Sciences66%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine18665.9%
    1. Immunology and Microbiology4515.9%
    2. Biochemistry, Genetics and Molecular Biology176.0%
  3. Everything else258.8%
    1. Engineering103.4%
  1. 1Oncology35% of their works
  2. 2Radiology, Nuclear Medicine and Imaging27% of their works
  3. 3Immunology16% of their works
  4. 4Molecular Biology6% of their works
  5. 5Biomedical Engineering3% of their works
  6. 6Pathology and Forensic Medicine3% of their works

Research topics

Which keywords describe Johannes Sam's research?

The keywords of their largest research topics: Cancer Immunotherapy, Lymphoma, Monoclonal Antibodies, CAR T Cells, Chimeric Antigen Receptor, Fc Receptors, Therapeutic Antibodies and PET Imaging.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 20 words, with their numbers
  1. Cancer Immunotherapy662 topics
  2. Lymphoma582 topics
  3. Monoclonal Antibodies552 topics
  4. CAR T Cells501 topic
  5. Chimeric Antigen Receptor501 topic
  6. Fc Receptors491 topic
  7. Therapeutic Antibodies491 topic
  8. PET Imaging222 topics
  9. Immune Checkpoint Blockade211 topic
  10. PD-1 and PD-L1211 topic
  11. Dendritic Cells161 topic
  12. Immunity161 topic
  13. Radiopharmaceuticals141 topic
  14. Targeted Therapy141 topic
  15. Classification81 topic
  16. Molecular Profiling81 topic
  17. Biosimilars61 topic
  18. Breast Cancer61 topic
  19. HER261 topic
  20. Immunogenicity61 topic

Where does Johannes Sam work?

Johannes Sam's main affiliation in the publication record is Roche (Switzerland), Switzerland.

How many publications and citations does Johannes Sam have?

OpenAlex counts 282 works and 2,915 citations for Johannes Sam, an h-index of 24, ranking #89,426 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Johannes Sam. Posts are plain text and can be reported.